小知了
Lv75
3238 积分
2023-05-08 加入
爱看书的虫~
-
A β-1,3/1,6-glucan enhances anti-tumor effects of PD1 antibody by reprogramming tumor microenvironment
2小时前
已完结
-
First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors
8天前
已完结
-
First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors
15天前
已完结
-
Image cytometric bcl‐2:bax and bcl‐2:bcl‐x ratios in invasive breast carcinoma: Correlation with prognosis
23天前
已关闭
-
Adenovirus‐mediated small hairpin RNA targeting Bcl‐XL as therapy for colon cancer
23天前
已完结
-
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
1个月前
已完结
-
Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
1个月前
已完结
-
Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC
1个月前
已完结
-
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
-
What influences the activity of Degrader−Antibody conjugates (DACs)
1个月前
已完结